State Street
ORGO icon

State Street’s Organogenesis Holdings ORGO Stock Holding History

State Street’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.61M Buy
1,525,108
+5,836
+0.4% +$20.2K ﹤0.01% 3085
2025
Q4 		$7.87M Sell
1,519,272
-1,642
-0.1% -$7.96K ﹤0.01% 2766
2025
Q3 		$6.42M Buy
1,520,914
+12,280
+0.8% +$57.1K ﹤0.01% 2885
2025
Q2 		$5.52M Sell
1,508,634
-432,243
-22% -$1.61M ﹤0.01% 2898
2025
Q1 		$8.38M Buy
1,940,877
+386,366
+25% +$1.56M ﹤0.01% 2640
2024
Q4 		$4.97M Buy
1,554,511
+94,744
+6% +$318K ﹤0.01% 2981
2024
Q3 		$4.17M Buy
1,459,767
+9,090
+0.6% +$25.5K ﹤0.01% 3047
2024
Q2 		$4.06M Sell
1,450,677
-1,117
-0.1% -$3K ﹤0.01% 3014
2024
Q1 		$4.12M Buy
1,451,794
+51,249
+4% +$174K ﹤0.01% 3005
2023
Q4 		$5.73M Buy
1,400,545
+90,389
+7% +$253K ﹤0.01% 2887
2023
Q3 		$4.17M Buy
1,310,156
+27,262
+2% +$86.6K ﹤0.01% 3009
2023
Q2 		$4.26M Buy
1,282,894
+5,594
+0.4% +$16.5K ﹤0.01% 3075
2023
Q1 		$2.72M Sell
1,277,300
-1,207,063
-49% -$2.98M ﹤0.01% 3226
2022
Q4 		$6.68M Buy
2,484,363
+437,076
+21% +$1.27M ﹤0.01% 2903
2022
Q3 		$6.63M Sell
2,047,287
-4,123,302
-67% -$18.6M ﹤0.01% 2922
2022
Q2 		$30.1M Buy
6,170,589
+1,750,534
+40% +$10.8M ﹤0.01% 1961
2022
Q1 		$33.7M Sell
4,420,055
-980,805
-18% -$7.59M ﹤0.01% 2020
2021
Q4 		$49.9M Buy
5,400,860
+1,341,450
+33% +$14.2M ﹤0.01% 1802
2021
Q3 		$57.8M Sell
4,059,410
-185,271
-4% -$2.88M ﹤0.01% 1711
2021
Q2 		$70.5M Buy
4,244,681
+3,861,302
+1,007% +$72M ﹤0.01% 1586
2021
Q1 		$6.99M Buy
383,379
+28,550
+8% +$387K ﹤0.01% 2902
2020
Q4 		$2.67M Buy
354,829
+95,815
+37% +$455K ﹤0.01% 3246
2020
Q3 		$995K Buy
259,014
+64,493
+33% +$255K ﹤0.01% 3438
2020
Q2 		$747K Buy
194,521
+22,733
+13% +$82K ﹤0.01% 3479
2020
Q1 		$555K Buy
171,788
+7,028
+4% +$30.1K ﹤0.01% 3423
2019
Q4 		$792K Buy
164,760
+38,917
+31% +$247K ﹤0.01% 3448
2019
Q3 		$827K Buy
125,843
+2,837
+2% +$15.8K ﹤0.01% 3435
2019
Q2 		$593K Buy
+123,006
New +$904K ﹤0.01% 3487

Other funds holding ORGO

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

State Street's ORGO Position: Q1 2026 in Review

State Street increased its Organogenesis Holdings (ORGO) stake by 0.38% in Q1 2026, buying an estimated $20.2K and bringing the position to 1,525,108 shares worth $3.61M. The position accounts for ﹤0.01% of the portfolio, ranked #3085.

State Street first reported a position in ORGO in Q2 2019 and has held it in 28 quarters since. The position peaked at $70.5M in Q2 2021. 121 funds tracked by Wall St. Rank hold ORGO as of Q1 2026.

  • State Street held 1,525,108 shares of Organogenesis Holdings worth $3.61M as of Q1 2026.
  • State Street bought 5,836 Organogenesis Holdings shares in Q1 2026, an estimated $20.2K.
  • Organogenesis Holdings made up ﹤0.01% of State Street's portfolio in Q1 2026, its #3085 holding.
  • State Street first reported a position in Organogenesis Holdings in Q2 2019 and has held it in 28 quarters since.
  • State Street's Organogenesis Holdings position peaked at $70.5M in Q2 2021.
  • 121 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q1 2026.

Based on State Street's 13F filing for Q1 2026, filed 15 May 2026.